drugset / Trial / NCT06135168

A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different Preparations

NCT06135168

Phase 1 Completed 60 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
RandomizedParallel-groupTriple-blindOther

Summary

The purpose of this study is to compare the pharmacokinetics of the two different PEG-rhGH preparations after a single administration.

Timeline

Start
2023-10-31
Primary completion
2023-11-29
Completion
2024-03-18

Drugs

EvaluationDrugModalityDoseRoute
Subject PEG-rhGH Protein / enzyme biologic Subcutaneous

Indications